Takeda Makoto, Ohno Shinji, Tahara Maino, Takeuchi Hiroki, Shirogane Yuta, Ohmura Hirofumi, Nakamura Takafumi, Yanagi Yusuke
Department of Virology, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
J Virol. 2008 Dec;82(23):11979-84. doi: 10.1128/JVI.00867-08. Epub 2008 Sep 17.
Live attenuated vaccines against measles have been developed through adaptation of clinical isolates of measles virus (MV) in various cultured cells. Analyses using recombinant MVs with chimeric genomes between wild-type and Edmonston vaccine strains indicated that viruses possessing the polymerase protein genes of the Edmonston strain exhibited attenuated viral gene expression and growth in cultured cells as well as in mice expressing an MV receptor, signaling lymphocyte activation molecule, regardless of whether the virus genome had the wild-type or vaccine-type promoter sequence. These data demonstrate that the polymerase protein genes of the Edmonston strain contribute to its attenuated phenotype.
通过在各种培养细胞中对麻疹病毒(MV)临床分离株进行适应性改造,已开发出减毒活麻疹疫苗。使用野生型和埃德蒙斯顿疫苗株之间具有嵌合基因组的重组MV进行的分析表明,无论病毒基因组具有野生型还是疫苗型启动子序列,拥有埃德蒙斯顿株聚合酶蛋白基因的病毒在培养细胞以及表达MV受体(信号淋巴细胞激活分子)的小鼠中均表现出病毒基因表达减弱和生长受抑制。这些数据表明,埃德蒙斯顿株的聚合酶蛋白基因促成了其减毒表型。